Supporting innovation for better, more effective Alzheimer's treatments
EMIF-AD studies: cardiovascular health and risk of dementia
Pieter Jelle Visser
What are the benefits of collaborating with the Drug Discovery Institute?
A bright future for dementia research
Quantitative neuropathological assessment to investigate the multi-morbid old brain